Advertisement
Cord Blood America, in its acquisition of CorCell, has strongrelationships in both Philadelphia and Pittsburgh with health insurers and themedical community. CorCell's sales and marketing are based in Philadelphia.
Advertisement
"It is so important that families be informed about the benefits ofumbilical cord blood storage, which is safe, non-controversial and is alreadyused to treat more than 70 serious diseases, including various blood cancerssuch as leukemia, lymphoma and myelomas such as Hodgkin's Disease, and blooddiseases including anemia and immune deficient disorders," said MatthewSchissler, CEO, Cord Blood America.
"We salute Pennsylvania for joining New York and California in taking thelead in providing solid, reliable information to potential new parents andbelieve this trend will continue in many more states," Mr. Schissler said.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company ofCorCell, which facilitates umbilical cord blood stem cell preservation forexpectant parents and their children. Its mission is to be the most respectedstem cell preservation company in the industry. Collected through a safe andnon-invasive process, cord blood stem cells offer a powerful and potentiallylife-saving resource for treating a growing number of ailments, includingcancer, leukemia, blood, and immune disorders. To find out more about CordBlood America, Inc. (OTC Bulletin Board: CBAI), visit our website athttp://www.corcell.com. For investor information, visithttp://www.cordblood-america.com.CONTACT: Paul Knopick E & E Communications 949/707-5365 [email protected]
SOURCE Cord Blood America, Inc.
